Schedule I (Tables)

12 Months Ended

Dec. 31, 2022

Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Balance Sheets


(in millions, except per share data)	December 31, 2022		December 31, 2021
Assets
Current assets:
Cash and cash equivalents	$	266	$	2,167
Other current assets	753		503
Total current assets	1,019		2,670
Equity in net assets of subsidiaries	136,562		116,907
Long-term notes receivable from subsidiaries	6,201		5,680
Other assets	504		32
Total assets	$	144,286	$	125,289

Liabilities and shareholders’ equity
Current liabilities:
Accounts payable and accrued liabilities	$	835	$	605
Current portion of notes payable to subsidiaries	8,699		8,105
Short-term borrowings and current maturities of long-term debt	2,918		3,009
Total current liabilities	12,452		11,719
Long-term debt, less current maturities	53,838		41,623
Other liabilities	224		187
Total liabilities	66,514		53,529
Commitments and contingencies (Note 4)
Shareholders’ equity:
Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding	—		—
Common stock, $0.01 par value - 3,000 shares authorized; 934 and 941 issued and outstanding	9		10
Retained earnings	86,156		77,134
Accumulated other comprehensive loss	(8,393)		(5,384)
Total UnitedHealth Group shareholders’ equity	77,772		71,760
Total liabilities and shareholders’ equity	$	144,286	$	125,289

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Statements of Comprehensive Income


	For the Years Ended December 31,
(in millions)	2022		2021		2020
Revenues:
Investment and other income	$	255	$	494	$	194
Total revenues	255		494		194
Operating costs:
Operating costs	121		40		27
Interest expense	2,110		1,583		1,594
Total operating costs	2,231		1,623		1,621
Loss before income taxes	(1,976)		(1,129)		(1,427)
Benefit for income taxes	429		231		300
Loss of parent company	(1,547)		(898)		(1,127)
Equity in undistributed income of subsidiaries	21,667		18,183		16,530
Net earnings	20,120		17,285		15,403
Other comprehensive loss	(3,009)		(1,570)		(236)
Comprehensive income	$	17,111	$	15,715	$	15,167

Condensed Financial Information of Registrant

(Parent Company Only)

UnitedHealth Group

Condensed Statements of Cash Flows


	For the Years Ended December 31,
(in millions)	2022		2021		2020
Operating activities
Cash flows from operating activities	$	14,754	$	11,439	$	8,842
Investing activities
Issuances of notes to subsidiaries	(567)		(444)		(628)
Repayments of notes to subsidiaries	281		37		1,089
Cash paid for acquisitions	(20,728)		(4,953)		(7,706)
Return of capital to parent company	1,424		245		943
Capital contributions to subsidiaries	(570)		(747)		(43)
Cash received from dispositions	2,787		—		143
Cash flows used for investing activities	(17,373)		(5,862)		(6,202)
Financing activities
Common stock repurchases	(7,000)		(5,000)		(4,250)
Proceeds from common stock issuances	1,253		1,355		1,440
Cash dividends paid	(5,991)		(5,280)		(4,584)
Proceed from (repayments of) short-term borrowings, net	732		(1,302)		872
Proceeds from issuance of long-term debt	14,819		6,933		4,864
Repayments of long-term debt	(3,015)		(3,150)		(3,150)
Proceeds from notes from subsidiaries	594		3,223		2,818
Other, net	(674)		(447)		(438)
Cash flows from (used for) financing activities	718		(3,668)		(2,428)
(Decrease) increase in cash and cash equivalents	(1,901)		1,909		212
Cash and cash equivalents, beginning of period	2,167		258		46
Cash and cash equivalents, end of period	$	266	$	2,167	$	258

Supplemental cash flow disclosures
Cash paid for interest	$	1,969	$	1,575	$	1,633
Cash paid for income taxes	4,298		3,050		4,185

Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows: